Monday, October 2, 2023 10/2/2023

Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention

Award Number: R01DA047954
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY The proposed study addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders (SUDs) in primary care (PC). reSET and reSET-O are smartphone-based, FDA-cleared versions of the Therapeutic Educational System, which is a computerized cognitive-behavioral treatment for SUDs. We will study their implementation into PC to potentially improve care for people with SUDs, and as a model for how to sustainably implement digital treatments into real-world healthcare. Digital treatments could extend the reach of SUD therapy to more people and could address a significant barrier to buprenorphine prescribing in PC: the lack of access to psychosocial treatment. Delivery system leaders in Kaiser Permanente Washington are our collaborators for studying strategies for implementing reSET and reSET-O in Washington State to address prior implementation challenges documented in the literature. After piloting in 2 clinics, we will randomize up to 23 PC clinics in a 2x2 factorial design to four approaches: (1) “standard implementation,” which is an evidence-based implementation strategy previously used by our delivery system partners; (2) “standard implementation with external facilitation,” a clinician-facing implementation strategy; (3) “standard implementation with patient coach,” a patient-facing implementation strategy using medical assistants to support patient adoption and engagement; and (4) “standard implementation with both.” These implementation strategies have some evidence in PC, but their impact on real-world implementation of a digital treatment has not been evaluated. Specific Aims are to (1) Estimate the effect of clinician-facing (external facilitation) and patient-facing (patient coach) implementation strategies in increasing the reach and fidelity of a digital SUD treatment in PC clinics, and (2) compare the population-level cost-effectiveness of each implementation strategy in increasing reach, fidelity, and abstinence by patients. This administrative supplement will allow our study to recover from COVID-related delays and (3) estimate the impact of: training non-social work clinicians to prescribe reSET and reSET-O, allowing prescriptions without requiring follow-up visits, and centralizing the administrative tasks of prescribing. IMPACT: Researchers and health systems do not know how to reach large numbers of patients with OUDs and other SUDs. Digital treatments are promising, but health systems lack evidence to guide implementation of digital therapies. This study will estimate and compare the effectiveness of clinician-facing and patient-facing implementation strategies, providing health system leaders with data on how to best implement digital treatments.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $983,265 )
2023	2023	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	000	5	2/13/2023	NON-COMPETING CONTINUATION	$596,287
2023	2023	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	001	5	6/16/2023	SUPPLEMENT FOR EXPANSION	$386,978


Issue Date FY: 2022 ( Subtotal = $663,241 )
2022	2022	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	000	4	2/2/2022	NON-COMPETING CONTINUATION	$596,918
2022	2022	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	001	4	3/21/2022	NON-COMPETING CONTINUATION	$66,323


Issue Date FY: 2021 ( Subtotal = $689,984 )
2021	2021	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	000	3	2/11/2021	NON-COMPETING CONTINUATION	$689,984


Issue Date FY: 2020 ( Subtotal = $743,340 )
2020	2020	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	000	2	1/30/2020	NON-COMPETING CONTINUATION	$743,340


Issue Date FY: 2019 ( Subtotal = $779,824 )
2019	2019	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Drug Abuse and Addiction Research Programs	000	1	3/28/2019	NEW	$779,824


Grand Total All Awards = $3,859,654

Sum of Action Amount is $3,859,654;

Grand Total = $3,859,654

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention

Award Number: R01DA047954

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer